Your Path to Hope Resources

I was able to attend The Society of Neuro-Oncology annual meeting in November 2022 and learned an amazing amount about what the field is focusing on and how it can pave the way for future treatments of this horrible disease.

DJ utilized the innovative Tumor-Treating Fields technology by wearing the Optune device for 2 years. Last year, DJ joined the Head for the Cure staff as its Community Outreach Coordinator.

For the first time in 12 years, glioblastoma patients in Canada have a new treatment option.

A brain tumor diagnosis can be overwhelming, but fortunately, various proven FDA-cleared and FDA-approved treatment options are available.

President Joe Biden, First Lady Jill Biden, Vice President Kamala Harris, and the entire Biden-Harris Administration are reviving Cancer Moonshot. While serving as Vice President, Joe Biden initially launched Cancer Moonshot. With this renewed energy, the administration has set incredible goals “to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and their families living with and surviving cancer— and, by doing this and more, end cancer as we know it today.”

Tomorrow will mark another year remembering Steve Damm through Acts of Kindness. On what would have been Steve’s 43rd birthday, the Damm family created “43 Acts of Kindness”. They were concerned they may not be able to complete the task, but through the power of social media, they had more than 400 acts of kindness that year. Each year this tradition continues in Frisco, Texas, and across the country and globe. Whether you purchase a stranger coffee or lunch, make a generous donation, or deliver a friendly card, the point is to simply be kind to others.

The Ivy Brain Tumor Center at Barrow Neurological Institute and SonALAsense announced positive results in their first-in-human Phase 0/1 clinical trial of SDT in recurrent glioblastoma patients. The initial results were presented at the European Society for Medical Oncology Congress today by Nader Sanai, MD, Director of the Ivy Brain Tumor Center. “The Ivy Center’s Phase 0/1 study has shown a promising translation of the preclinical results of SDT in patients with glioblastoma.

Since I started my training, there was the establishment of what’s currently the standard of care. Which is the concurrent use of radiation and temozolomide and adjuvant temozolomide. That, unfortunately, has not changed though, in the last 15 years. So although I got to see the transformation of the field and maybe for the first time, a large number of patients who have five years and beyond survival, we still have not been able to really make that a reality for a majority of patients. So we’ve unfortunately had some limitations in the advancements since that time.

Today, July 21st, marks the 3rd Annual Glioblastoma (GBM) Awareness Day. Brains for the Cure invites you to join us, Head for the Cure, and the entire brain tumor community on honoring this important day! …

Medulloblastoma is a deadly form of pediatric brain cancer that strikes the cerebellum, a brain structure near the base of the skull. When it spreads to the lining of the brain or spinal cord, it …